| P2093 | author name string | Kawakami M | |
| | Kawakami K | |
| | Puri RK | |
| | Husain SR | |
| P2860 | cites work | Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex | Q24317071 |
| | Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses | Q28115227 |
| | Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain | Q28188959 |
| | The IL-4 receptor: signaling mechanisms and biologic functions | Q28198739 |
| | Cancer statistics, 2002 | Q28216788 |
| | Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain | Q28281946 |
| | cDNA cloning and characterization of the human interleukin 13 receptor alpha chain | Q28296335 |
| | Mutation and Functional Analysis of IL-13 Receptors in Human Malignant Glioma Cells | Q29037698 |
| | Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor | Q33633115 |
| | Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice | Q34007894 |
| | Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. | Q35823623 |
| | Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo. | Q35943966 |
| | In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice | Q36369794 |
| | Current management of pancreatic carcinoma | Q40397669 |
| | Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer | Q40651599 |
| | Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells | Q40748434 |
| | Conversion of interleukin-13 into a high affinity agonist by a single amino acid substitution | Q40881849 |
| | Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway | Q41011905 |
| | Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells | Q41090719 |
| | Modulation of interleukin (IL)-13 binding and signaling by the gammac chain of the IL-2 receptor | Q41094556 |
| | Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction | Q41133816 |
| | Improved DNA: liposome complexes for increased systemic delivery and gene expression | Q41633695 |
| | Interleukin-13 receptor as a unique target for anti-glioblastoma therapy | Q43567315 |
| | Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. | Q43620898 |
| | Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts | Q43843857 |
| | Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin‐13 | Q45868306 |
| | Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial | Q45876506 |
| | Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. | Q50113265 |
| | In vitro and in vivo suppression of interleukin-2-activated killer cell activity by chimeric proteins between interleukin-2 and Pseudomonas exotoxin | Q68026636 |
| | A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 | Q71921204 |
| | NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway | Q73256881 |
| | The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway | Q73784963 |
| | Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain | Q74313373 |
| P433 | issue | 13 | |
| P304 | page(s) | 1116-1128 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo | |
| P478 | volume | 10 | |